Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
(What Research Shows) Without controlled human trials published in peer-reviewed journals, calling any research peptide 'safe' is speculative at best
Weeks 1-4: 2mg once weekly Weeks 5-8: 4mg once weekly Weeks 9-12: 8mg once weekly Week 13 onward: 12mg once weekly (maintenance) Total escalation time spans 12 weeks, slower than some competitors but necessary given the triple-receptor mechanism
This product is intended exclusively for laboratory, educational, and scientific research applications
In a clinical study, recombinant human (rh)-EPO showed effective attenuation of ARDS symptoms and facilitated recovery from COVID-19 via multiple mechanisms including cytokine modulation, anti-apoptotic effects and leukocyte release from the bone marrow 475
US$ 24.52
US$ 27.69
US$ 20.05
